Soy for cardiovascular indications

American Journal of Health-System Pharmacy

Volumn 58, Issue 8, 2001, Pages 663-666

  Chester, Elizabeth A ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOESTROGEN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; DRUG RESEARCH; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SOYBEAN;

EID: 0035871339     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.8.663     Document Type: Short Survey

References (18)

1. Jellin JM, Batz F, Hitchens K. Pharmacist's letter/prescriber's letter natural medicines comprehensive database. Stockton, CA: Therapeutic Research Faculty; 1999:780-1.
2. DerMarderosian A, ed. Review of natural products. St. Louis: Facts and Comparisons; 1998.
3. North American Menopause Society Advisory Panel. Consensus opinion. The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society. Menopause. 2000; 7:215-29.
4. Wroblewski-Lissin L, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol. 2000; 35:1403-10.
5. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol. 1996; 87:897-904.
6. Umland EM, Cauffield JS, Kirk JK et al. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy. 2000; 20:981-90.
7. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995; 333:276-82.
8. Potter SM, Baum JA, Teng H et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998; 68(suppl):1375s-9s.
9. Baum JA, Teng H, Erdman JW et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998; 68:545-51.
10. Wong WW, Smith EO, Stuff JE et al. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998; 68(suppl):1385s-9s.
11. Washburn S, Burke GL, Morgan T et al. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999; 6:7-13.
12. Crouse JR, Morgan T, Terry JG et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999; 159:2070-6.
13. Anthony MS, Clarkson TB. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in postmenopausal monkeys. Circulation. 1998; 97:829. Abstract.
14. Dubey RK, Gillespie DG, Imthurn B et al. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension. 1999; 33:177-82.
15. Nestel PJ, Yamashita T, Sasahara T et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997; 17:3392-8.
16. Nestel PJ, Pomeroy S, Kay S et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999; 84:895-8.
17. Tikkanen MJ, Wahala K, Ojala S et al. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A. 1998; 95:3106-10.
18. Scheiber MD, Setchell KDR, Liu JH et al. Dietary soy supplementation influences LDL oxidation and bone turnover in healthy postmenopausal women. Paper presented at 81st Meeting of the Endocrine Society. San Diego, CA; 1999 Jun.